Showing results (351-360 of 991) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|March 31, 2005
Cell biology of the neurovascular unit: implications for drug delivery across the blood-brain barrierJoseph H McCarty
Assay and Drug Development Technologies|May 29, 2004
Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunoassaysJames R Beasley, Paul M McCoy, Tiffany L Walker, et al.
Assay and Drug Development Technologies|May 29, 2004
Overcoming compound interference in fluorescence polarization-based kinase assays using far-red tracersKevin L Vedvik, Hildegard C Eliason, Randy L Hoffman, et al.
Assay and Drug Development Technologies|February 18, 2010
Validation of a Rb+ uptake assay for the mouse embryonic stem cell-derived cardiomyocytes Na+, K+ ATPaseSikander Gill, Rajwant Gill, Sophia Liang
Assay and Drug Development Technologies|November 20, 2009
Development of an improved IP(1) assay for the characterization of 5-HT(2C) receptor ligandsJean Y Zhang, Dianne M Kowal, Stanley P Nawoschik, et al.
Assay and Drug Development Technologies|December 29, 2009
A software framework enabling analysis of plate-based flow cytometry data for high-throughput screeningRick A Stanton, Sonia Escobar, Gary S Elliott
Assay and Drug Development Technologies|December 16, 2014
High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal culturesOksana Sirenko, Jayne Hesley, Ivan Rusyn, et al.
Assay and Drug Development Technologies|October 2, 2015
A High-Throughput Genetic Complementation Assay in Yeast Cells Identified Selective Inhibitors of Sphingosine Kinase 1 Not Found Using a Cell-Free Enzyme AssayMohammed A Kashem, Charles A Kennedy, Kylie E Fogarty, et al.
Assay and Drug Development Technologies|August 7, 2015
High-content assay for measuring intracellular growth of Leishmania in human macrophagesMichael J Dagley, Eleanor C Saunders, Kaylene J Simpson, et al.
Assay and Drug Development Technologies|August 29, 2015
HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell linesPaul A Johnston, Malabika Sen, Yun Hua, et al.
Pageof 100